There is a good chance that Patrick Swayze may receive hopeful treatment from pancreatic cancer due to the surgery, reports BBC.

According to a report provided by CNS and published at AHN Media Patrick Swayze while receiving treatment from Pancreatic Cancer is responding well to the disease and is not dying in five weeks. Earlier reports are untrue about Swayze daying in 5 weeks.

Research shows that adding chemotherapy to chemoradiation treatment following surgery for pancreatic cancer appears to have limited survival benefit.

Patrick Swayze was reportedly diagnosed with pancreatic cancer in late January. New reports allege that the cancer has spread to other organs and doctors have given his only 5 more weeks to live.

The addition of the drug gemcitabine with chemoradiation for the treatment of patients who had surgery for pancreatic cancer was associated with a survival benefit, although this improvement was not statistically significant, according to a study in the March 5 issue of JAMA.

Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).

New understanding of a protein that spurs the growth of pancreatic cancer could lead to a new vaccine against the deadly disease, said researchers at Baylor College of Medicine in Houston in a report appearing in the current edition of the journal Molecular Cancer Therapeutics.

A protein that helps prevent a woman’s body from rejecting a fetus may also play an important role in enabling pancreatic cancer cells to evade detection by the immune system, allowing them to spread in the body.

At least 1 percent of hospitalized patients at major medical centers will have a pancreatic cystic lesion on cross sectional imaging, and up to one-quarter of all pancreata examined in an autopsy series contained a pancreatic cyst.

An intestinal protein known as BSDL that helps the body breakdown and absorb cholesterol is also found circulating in our bloodstream, where its role has been an enigma. However, in a new study, Laurence Panicot-Dubois and his colleagues at the Université de la Méditerranée, France, have identified a role for blood-borne BSDL in blood clot formation.

Zinc, an important trace element for healthy growth and development, can be related to pancreatic cancer.

A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered that the protein, pp32 – which normally applies the brakes on a cancer-causing gene – is missing in an aggressive form of pancreatic cancer.